Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: US Preventive Services Task Force Recommendation Statement

被引:232
作者
Siu, Albert L. [1 ]
机构
[1] US Prevent Serv Task Force, Rockville, MD USA
关键词
IMPAIRED FASTING GLUCOSE; LIFE-STYLE INTERVENTION; ALL-CAUSE MORTALITY; LOW-DOSE ASPIRIN; FOLLOW-UP; CARDIOVASCULAR OUTCOMES; PRESSURE CONTROL; ADDITION-EUROPE; PEOPLE; TOLERANCE;
D O I
10.7326/M15-2345
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Description: Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for diabetes in asymptomatic adults. Methods: The USPSTF reviewed the evidence on screening for impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes in asymptomatic, nonpregnant adults who are at average or high risk for diabetes and its complications. Population: This recommendation applies to adults aged 40 to 70 years seen in primary care settings who do not have symptoms of diabetes and are overweight or obese. Recommendation: The USPSTF recommends screening for abnormal blood glucose as part of cardiovascular risk assessment in adults aged 40 to 70 years who are overweight or obese. Clinicians should offer or refer patients with abnormal blood glucose to intensive behavioral counseling interventions to promote a healthful diet and physical activity. (B recommendation)
引用
收藏
页码:861 / +
页数:9
相关论文
共 51 条
  • [21] Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: A Simulation of the Results of the Anglo-Danish-Dutch Study of Intensive Treatment in People With Screen-Detected Diabetes in Primary Care (ADDITION-Europe)
    Herman, William H.
    Ye, Wen
    Griffin, Simon J.
    Simmons, Rebecca K.
    Davies, Melanie J.
    Khunti, Kamlesh
    Rutten, Guy E. H. M.
    Sandbaek, Annelli
    Lauritzen, Torsten
    Borch-Johnsen, Knut
    Brown, Morton B.
    Wareham, Nicholas J.
    [J]. DIABETES CARE, 2015, 38 (08) : 1449 - 1455
  • [22] Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular Events
    Holman, Rury R.
    Haffner, Steven M.
    McMurray, John J.
    Bethel, M. Angelyn
    Holzhauer, Bjoern
    Hua, Tsushung A.
    Belenkov, Yuri
    Boolell, Mitradev
    Buse, John B.
    Buckley, Brendan M.
    Chacra, Antonio R.
    Chiang, Fu-Tien
    Charbonnel, Bernard
    Chow, Chun-Chung
    Davies, Melanie J.
    Deedwania, Prakash
    Diem, Peter
    Einhorn, Daniel
    Fonseca, Vivian
    Fulcher, Gregory R.
    Gaciong, Zbigniew
    Gaztambide, Sonia
    Giles, Thomas
    Horton, Edward
    Ilkova, Hasan
    Jenssen, Trond
    Kahn, Steven E.
    Krum, Henry
    Laakso, Markku
    Leiter, Lawrence A.
    Levitt, Naomi S.
    Mareev, Viacheslav
    Martinez, Felipe
    Masson, Chantal
    Mazzone, Theodore
    Meaney, Eduardo
    Nesto, Richard
    Pan, Changyu
    Prager, Rudolf
    Raptis, Sotirios A.
    Rutten, Guy E. H. M.
    Sandstroem, Herbert
    Schaper, Frank
    Scheen, Andre
    Schmitz, Ole
    Sinay, Isaac
    Soska, Vladimir
    Stender, Steen
    Tamas, Gyula
    Tognoni, Gianni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (16) : 1463 - 1476
  • [23] Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes - The SANDS randomized trial
    Howard, Barbara V.
    Roman, Mary J.
    Devereux, Richard B.
    Fleg, Jerome L.
    Galloway, James M.
    Henderson, Jeffrey A.
    Howard, Wm. James
    Lee, Elisa T.
    Mete, Mihriye
    Poolaw, Bryce
    Ratner, Robert E.
    Russell, Marie
    Silverman, Angela
    Stylianou, Mario
    Umans, Jason G.
    Wang, Wenyu
    Weir, Matthew R.
    Weissman, Neil J.
    Wilson, Charlton
    Yeh, Fawn
    Zhu, Jianhui
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (14): : 1678 - 1689
  • [24] Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis
    Kahn, Richard
    Alperin, Peter
    Eddy, David
    Borch-Johnsen, Knut
    Buse, John
    Feigelman, Justin
    Gregg, Edward
    Holman, Rury R.
    Kirkman, M. Sue
    Stern, Michael
    Tuomilehto, Jaakko
    Wareham, Nick J.
    [J]. LANCET, 2010, 375 (9723) : 1365 - 1374
  • [25] Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X
  • [26] Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
    Knowler, WC
    Barrett-Connor, E
    Fowler, SE
    Hamman, RF
    Lachin, JM
    Walker, EA
    Nathan, DM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (06) : 393 - 403
  • [27] The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
    Li, Guangwei
    Zhang, Ping
    Wang, Jinping
    Gregg, Edward W.
    Yang, Wenying
    Gong, Qiuhong
    Li, Hui
    Li, Hongliang
    Jiang, Yayun
    An, Yali
    Shuai, Ying
    Zhang, Bo
    Zhang, Jingling
    Thompson, Theodore J.
    Gerzoff, Robert B.
    Roglic, Gojka
    Hu, Yinghua
    Bennett, Peter H.
    [J]. LANCET, 2008, 371 (9626) : 1783 - 1789
  • [28] Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
    Li, Guangwei
    Zhang, Ping
    Wang, Jinping
    An, Yali
    Gong, Qiuhong
    Gregg, Edward W.
    Yang, Wenying
    Zhang, Bo
    Shuai, Ying
    Hong, Jing
    Engelgau, Michael M.
    Li, Hui
    Roglic, Gojka
    Hu, Yinghua
    Bennett, Peter H.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (06) : 474 - 480
  • [29] Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
    McMurray, John J.
    Holman, Rury R.
    Haffner, Steven M.
    Bethel, M. Angelyn
    Holzhauer, Bjoern
    Hua, Tsushung A.
    Belenkov, Yuri
    Boolell, Mitradev
    Buse, John B.
    Buckley, Brendan M.
    Chacra, Antonio R.
    Chiang, Fu-Tien
    Charbonnel, Bernard
    Chow, Chun-Chung
    Davies, Melanie J.
    Deedwania, Prakash
    Diem, Peter
    Einhorn, Daniel
    Fonseca, Vivian
    Fulcher, Gregory R.
    Gaciong, Zbigniew
    Gaztambide, Sonia
    Giles, Thomas
    Horton, Edward
    Ilkova, Hasan
    Jenssen, Trond
    Kahn, Steven E.
    Krum, Henry
    Laakso, Markku
    Leiter, Lawrence A.
    Levitt, Naomi S.
    Mareev, Viacheslav
    Martinez, Felipe
    Masson, Chantal
    Mazzone, Theodore
    Meaney, Eduardo
    Nesto, Richard
    Pan, Changyu
    Prager, Rudolf
    Raptis, Sotirios A.
    Rutten, Guy E. H. M.
    Sandstroem, Herbert
    Schaper, Frank
    Scheen, Andre
    Schmitz, Ole
    Sinay, Isaac
    Soska, Vladimir
    Stender, Steen
    Tamas, Gyula
    Tognoni, Gianni
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (16) : 1477 - 1490
  • [30] Impact of screening and early detection of impaired fasting glucose tolerance and type 2 diabetes in Canada: a Markov model simulation
    Mortaz, Soroush
    Wessman, Christine
    Duncan, Ross
    Gray, Rachel
    Badawi, Alaa
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2012, 4 : 91 - 97